FcγRI mediates serum amyloid P inhibition of fibrocyte differentiation

Journal of Leukocyte Biology

Volumn 92, Issue 4, 2012, Pages 699-711

  Crawford, Jeffrey R ^a   Pilling, Darrell ^b   Gomer, Richard H ^a,b  

^a RICE UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

CD32; CD64; Monocyte; Pentraxin; SAP

Indexed keywords

FC RECEPTOR; FC RECEPTOR IIB; FC RECEPTOR IIIA; FC RECEPTOR IV; SERUM AMYLOID P; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL COUNT; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; FIBROCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MESENCHYME CELL; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; SPLEEN CELL;

ANIMALS; CELL DIFFERENTIATION; FIBROBLASTS; HEK293 CELLS; HUMANS; INTERLEUKIN-13; MACROPHAGE COLONY-STIMULATING FACTOR; MICE; MICE, INBRED C57BL; MONOCYTES; RECEPTORS, IGG; RECOMBINANT PROTEINS; RNA, SMALL INTERFERING; SERUM AMYLOID P-COMPONENT;

ANIMALIA; MURINAE;

EID: 84868117632     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0112033     Document Type: Article

References (70)

1. Kumar, V., Abbas, A. K., Fausto, N., Kumar, V., Abbas, A. K., Fausto, N. (2005) Tissue renewal and repair: regeneration, healing, and fibrosis. In Robbins and Cotran: Pathological Basis of Disease, vol. 7, Elsevier Saunders, Philadelphia, PA, 87-118.
2. Bouros, D., Antoniou, K. M. (2005) Current and future therapeutic approaches in idiopathic pulmonary fibrosis. Eur. Respir. J. 26, 693-703.
3. Gomer, R. H., Lupher M. L., Jr., (2010) Investigational approaches to therapies for idiopathic pulmonary fibrosis. Expert Opin. Investig. Drugs 19, 737-745.
4. Cowper, S. E. (2003) Nephrogenic fibrosing dermopathy: the first 6 years. Curr. Opin. Rheumatol. 15, 785-790.
5. Phillips, R. J., Burdick, M. D., Hong, K., Lutz, M. A., Murray, L. A., Xue, Y. Y., Belperio, J. A., Keane, M. P., Strieter, R. M. (2004) Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J. Clin. Invest. 114, 438-446.
6. Haudek, S. B., Xia, Y., Huebener, P., Lee, J. M., Carlson, S., Crawford, J. R., Pilling, D., Gomer, R. H., Trial, J., Frangogiannis, N. G., Entman, M. L. (2006) Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice. Proc. Natl. Acad. Sci. USA 103, 18284-18289.
7. Kisseleva, T., Uchinami, H., Feirt, N., Quintana-Bustamante, O., Segovia, J. C., Schwabe, R. F., Brenner, D. A. (2006) Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J. Hepatol. 45, 429-438.
8. Mehrad, B., Burdick, M. D., Zisman, D. A., Keane, M. P., Belperio, J. A., Strieter, R. M. (2007) Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease. Biochem. Biophys. Res. Commun. 353, 104-108.
9. Herzog, E. L., Bucala, R. (2010) Fibrocytes in health and disease. Exp. Hematol. 38, 548-556.
10. Sakai, N., Furuichi, K., Shinozaki, Y., Yamauchi, H., Toyama, T., Kitajima, S., Okumura, T., Kokubo, S., Kobayashi, M., Takasawa, K., Takeda, S., Yoshimura, M., Kaneko, S., Wada, T. (2010) Fibrocytes are involved in the pathogenesis of human chronic kidney disease. Hum. Pathol. 41, 672-678.
11. Bucala, R., Spiegel, L. A., Chesney, J., Hogan, M., Cerami, A. (1994) Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol. Med. 1, 71-81.
12. Abe, R., Donnelly, S. C., Peng, T., Bucala, R., Metz, C. N. (2001) Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J. Immunol. 166, 7556-7562.
13. Pilling, D., Buckley, C. D., Salmon, M., Gomer, R. H. (2003) Inhibition of fibrocyte differentiation by serum amyloid P. J. Immunol. 17, 5537-5546.
14. Gomperts, B. N., Strieter, R. M. (2007) Fibrocytes in lung disease. J. Leukoc. Biol. 82, 449-456.
15. Shao, D. D., Suresh, R., Vakil, V., Gomer, R. H., Pilling, D. (2008) Pivotal Advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation. J. Leukoc. Biol. 83, 1323-1333.
16. Pilling, D., Fan, T., Huang, D., Kaul, B., Gomer, R. H. (2009) Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PLoS ONE 4, e7475.
17. Reilkoff, R. A., Bucala, R., Herzog, E. L. (2011) Fibrocytes: emerging effector cells in chronic inflammation. Nat. Rev. Immunol. 11, 427-435.
18. Strieter, R. M., Keeley, E. C., Hughes, M. A., Burdick, M. D., Mehrad, B. (2009) The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis. J. Leukoc. Biol. 86, 1111-1118.
19. Mathai, S. K., Gulati, M., Peng, X., Russell, T. R., Shaw, A. C., Rubinowitz, A. N., Murray, L. A., Siner, J. M., Antin-Ozerkis, D. E., Montgomery, R. R., Reilkoff, R. A., Bucala, R. J., Herzog, E. L. (2010) Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype. Lab. Invest. 90, 812-823.
20. Mehrad, B., Burdick, M. D., Strieter, R. M. (2009) Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis. Int. J. Biochem. Cell Biol. 41, 1708-1718.
21. Gomer, R. H., Pilling, D. (2010) Fibrocytes and collagen producing cells of the peripheral blood. In Fibrocytes (Bucala, ed.), R. Singapore, World Scientific Publishing.
22. Steel, D. M., Whitehead, A. S. (1994) The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol. Today 15, 81-88.
23. Gewurz, H., Zhang, X. H., Lint, T. F. (1995) Structure and function of the pentraxins. Curr. Opin. Immunol. 7, 54-64.
24. Pepys, M. B., Booth, D. R., Hutchinson, W. L., Gallimore, J. R., Collins, P. M., Hohenester, E. (1997) Amyloid P component. A critical review. Amyloid 4, 274-295.
25. Emsley, J., White, H. E., O'Hara, B. P., Oliva, G., Srinivasan, N., Tickle, I. J., Blundell, T. L., Pepys, M. B., Wood, S. P. (1994) Structure of pentameric human serum amyloid P component. Nature 367, 338-345.
26. Aquilina, J. A., Robinson, C. V. (2003) Investigating interactions of the pentraxins serum amyloid P component and C-reactive protein by mass spectrometry. Biochem. J. 375, 323-328.
27. Lu, J., Marnell, L. L., Marjon, K. D., Mold, C., Du Clos, T. W., Sun, P. D. (2008) Structural recognition and functional activation of FcγR by innate pentraxins. Nature 456, 989-992.
28. Agrawal, A., Singh, P. P., Bottazzi, B., Garlanda, C., Mantovani, A. (2009) Pattern recognition by pentraxins. Adv. Exp. Med. Biol. 653, 98-116.
29. Pilling, D., Roife, D., Wang, M., Ronkainen, S. D., Crawford, J. R., Travis, E. L., Gomer, R. H. (2007) Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P. J. Immunol. 179, 4035-4044.
30. Castano, A. P., Lin, S. L., Surowy, T., Nowlin, B. T., Turlapati, S. A., Patel, T., Singh, A., Li, S., Lupher M. L., Jr., Duffield, J. S. (2009) Serum amyloid P inhibits fibrosis through Fc γ R-dependent monocytemacrophage regulation in vivo. Sci. Transl. Med. 1, 5ra13.
31. Moreira, A. P., Cavassani, K. A., Hullinger, R., Rosada, R. S., Fong, D. J., Murray, L., Hesson, D. P., Hogaboam, C. M. (2010) Serum amyloid P attenuates M2 macrophage activation and protects against fungal spore-induced allergic airway disease. J. Allergy Clin. Immunol. 126, 712-721. e7.
32. Ravetch, J. V., Bolland, S. (2001) IgG Fc receptors. Annu. Rev. Immunol. 19, 275-290.
33. Daeron, M. (1997) Fc receptor biology. Annu. Rev. Immunol. 15, 203-234.
34. Nimmerjahn, F. (2006) Activating and inhibitory FcγRs in autoimmune disorders. Springer Semin. Immunopathol. 28, 305-319.
35. Ravetch, J. V., Lanier, L. L. (2000) Immune inhibitory receptors. Science 290, 84-89.
36. Nimmerjahn, F., Ravetch, J. V. (2006) Fcγ receptors: old friends and new family members. Immunity 24, 19-28.
37. Ravetch, J. V., Kinet, J. P. (1991) Fc receptors. Annu. Rev. Immunol. 9, 457-492.
38. Pilling, D., Tucker, N. M., Gomer, R. H. (2006) Aggregated IgG inhibits the differentiation of human fibrocytes. J. Leukoc. Biol. 79, 1242-1251.
39. Nimmerjahn, F., Ravetch, J. V. (2008) Fcγ receptors as regulators of immune responses. Nat. Rev. Immunol. 8, 34-47.
40. Hughes, A. L. (1996) Gene duplication and recombination in the evolution of mammalian Fc receptors. J. Mol. Evol. 43, 4-10.
41. Bharadwaj, D., Mold, C., Markham, E., Du Clos, T. W. (2001) Serum amyloid P component binds to Fc γ receptors and opsonizes particles for phagocytosis. J. Immunol. 166, 6735-6741.
42. Grage-Griebenow, E., Flad, H. D., Ernst, M. (2001) Heterogeneity of human peripheral blood monocyte subsets. J. Leukoc. Biol. 69, 11-20.
43. Chi, M., Tridandapani, S., Zhong, W., Coggeshall, K. M., Mortensen, R. F. (2002) C-reactive protein induces signaling through Fc γ RIIa on HL-60 granulocytes. J. Immunol. 168, 1413-1418.
44. Mold, C., Baca, R., Du Clos, T. W. (2002) Serum amyloid P component and C-reactive protein opsonize apoptotic cells for phagocytosis through Fcγ receptors. J. Autoimmun. 19, 147-154.
45. Macdonald, S. L., Kilpatrick, D. C. (2006) Human serum amyloid P component binds to peripheral blood monocytes. Scand. J. Immunol. 64, 48-52.
46. Haudek, S. B., Trial, J., Xia, Y., Gupta, D., Pilling, D., Entman, M. L. (2008) Fc receptor engagement mediates differentiation of cardiac fibroblast precursor cells. Proc. Natl. Acad. Sci. 105, 10179-10184.
47. Crawford, J. R., Pilling, D., Gomer, R. H. (2010) Improved serum-free culture conditions for spleen-derived murine fibrocytes. J. Immunol. Methods 363, 9-20.
48. Murray, L. A., Rosada, R., Moreira, A. P., Joshi, A., Kramer, M. S., Hesson, D. P., Argentieri, R. L., Mathai, S., Gulati, M., Herzog, E. L., Hogaboam, C. M. (2010) Serum amyloid P therapeutically attenuates murine bleomycin-induced pulmonary fibrosis via its effects on macrophages. PLoS ONE 5, e9683.
49. Murray, L. A., Chen, Q., Kramer, M. S., Hesson, D. P., Argentieri, R. L., Peng, X., Gulati, M., Homer, R. J., Russell, T., van Rooijen, N., Elias, J. A., Hogaboam, C. M., Herzog, E. L. (2011) TGF-β driven lung fibrosis is macrophage dependent and blocked by serum amyloid P. Int. J. Biochem. Cell Biol. 43, 154-162.
50. Murray, L., Kramer, M., Hesson, D., Watkins, B., Fey, E., Argentieri, R., Shaheen, F., Knight, D., Sonis, S. (2010) Serum amyloid P ameliorates radiation-induced oral mucositis and fibrosis. Fibrogenesis Tissue Repair 3, 11.
51. Smulevitch, S., Bear, J., Alicea, C., Rosati, M., Jalah, R., Zolotukhin, A. S., von Gegerfelt, A., Michalowski, D., Moroni, C., Pavlakis, G. N., Felber, B. K. (2006) RTE and CTE mRNA export elements synergistically increase expression of unstable, Rev-dependent HIV and SIV mRNAs. Retrovirology 3, 6.
52. Pepys, M. B., Dash, A. C., Munn, E. A., Feinstein, A., Skinner, M., Cohen, A. S., Gewurz, H., Osmand, A. P., Painter, R. H. (1977) Isolation of amyloid P component (protein AP) from normal serum as a calciumdependent binding protein. Lancet 1, 1029-1031.
53. Gomer, R. H., Pilling, D., Kauvar, L., Ellsworth, S., Pissani, S., Real, L., Ronkainen, S. D., Roife, D., Ma, F., Davis, S. C. (2009) A serum amyloid P-binding hydrogel speeds healing of partial thickness wounds in pigs. Wound Repair Regen. 17, 397-404.
54. De Beer, F. C., Pepys, M. B. (1982) Isolation of human C-reactive protein and serum amyloid P component. J. Immunol. Methods 50, 17-31.
55. Pilling, D., Vakil, V., Gomer, R. H. (2009) Improved serum-free culture conditions for the differentiation of human and murine fibrocytes. J. Immunol. Methods 351, 62-70.
56. Hazenbos, W. L., Gessner, J. E., Hofhuis, F. M., Kuipers, H., Meyer, D., Heijnen, I. A., Schmidt, R. E., Sandor, M., Capel, P. J., Daeron, M., van de Winkel, J. G., Verbeek, J. S. (1996) Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc γ RIII (CD16) deficient mice. Immunity 5, 181-188.
57. Takai, T., Ono, M., Hikida, M., Ohmori, H., Ravetch, J. V. (1996) Augmented humoral and anaphylactic responses in Fc γ RII-deficient mice. Nature 379, 346-349.
58. Ioan-Facsinay, A., de Kimpe, S. J., Hellwig, S. M., van Lent, P. L., Hofhuis, F. M., van Ojik, H. H., Sedlik, C., da Silveira, S. A., Gerber, J., de Jong, Y. F., Roozendaal, R., Aarden, L. A., van den Berg, W. B., Saito, T., Mosser, D., Amigorena, S., Izui, S., van Ommen, G. J., van Vugt, M., van de Winkel, J. G., Verbeek, J. S. (2002) FcγRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity 16, 391-402.
59. Naik-Mathuria, B., Pilling, D., Crawford, J. R., Gay, A. N., Smith, C. W., Gomer, R. H., Olutoye, O. O. (2008) Serum amyloid P inhibits dermal wound healing. Wound Repair Regen. 16, 266-273.
60. Santhiago, M. R., Singh, V., Barbosa, F. L., Agrawal, V., Wilson, S. E. (2011) Monocyte development inhibitor PRM-151 decreases corneal myofibroblast generation in rabbits. Exp. Eye Res. 93, 810-817.
61. Hutchinson, W. L., Hohenester, E., Pepys, M. B. (2000) Human serum amyloid P component is a single uncomplexed pentamer in whole serum. Mol. Med. 6, 482-493.
62. Niedermeier, M., Reich, B., Rodriguez Gomez, M., Denzel, A., Schmidbauer, K., Gobel, N., Talke, Y., Schweda, F., Mack, M. (2009) CD4+ T cells control the differentiation of Gr1+ monocytes into fibrocytes. Proc. Natl. Acad. Sci. USA 106, 17892-17897.
63. Swirski, F. K., Nahrendorf, M., Etzrodt, M., Wildgruber, M., Cortez-Retamozo, V., Panizzi, P., Figueiredo, J. L., Kohler, R. H., Chudnovskiy, A., Waterman, P., Aikawa, E., Mempel, T. R., Libby, P., Weissleder, R., Pittet, M. J. (2009) Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 325, 612-616.
64. Vannella, K. M., McMillan, T. R., Charbeneau, R. P., Wilke, C. A., Thomas, P. E., Toews, G. B., Peters-Golden, M., Moore, B. B. (2007) Cysteinyl leukotrienes are autocrine and paracrine regulators of fibrocyte function. J. Immunol. 179, 7883-7890.
65. Haudek, S. B., Cheng, J., Du, J., Wang, Y., Hermosillo-Rodriguez, J., Trial, J., Taffet, G. E., Entman, M. L. (2010) Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy. J. Mol. Cell. Cardiol. 49, 499-507.
66. Maharjan, A. S., Pilling, D., Gomer, R. H. (2010) Toll-like receptor 2 agonists inhibit human fibrocyte differentiation. Fibrogenesis Tissue Repair 3, 23.
67. Maharjan, A. S., Pilling, D., Gomer, R. H. (2011) High and low molecular weight hyaluronic acid differentially regulate human fibrocyte differentiation. PLoS ONE 6, e26078.
68. Schmidt, M., Sun, G., Stacey, M. A., Mori, L., Mattoli, S. (2003) Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J. Immunol. 171, 380-389.
69. Mori, L., Bellini, A., Stacey, M. A., Schmidt, M., Mattoli, S. (2005) Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow. Exp. Cell. Res. 304, 81-90.
70. Quan, T. E., Bucala, R. (2007) Culture and analysis of circulating fibrocytes. Methods Mol. Med. 135, 423-434.